Hoepner AGF - Search Results

1

Multiple Sclerosis immunotherapies and COVID-19 mortality: an analysis of the FDA Adverse Event Reporting System.

Pistor M, Hoepner R, Hoepner AGF, Lin Y, Jung S, Bassetti CL, Chan A, Salmen A. Pistor M, et al. Among authors: hoepner agf. Ther Adv Neurol Disord. 2022 Oct 10;15:17562864221129383. doi: 10.1177/17562864221129383. eCollection 2022. Ther Adv Neurol Disord. 2022. PMID: 36237201 Free PMC article.

2

Vitamin D supplementation differentially affects seasonal multiple sclerosis disease activity.

Miclea A, Miclea M, Pistor M, Hoepner A, Chan A, Hoepner R. Miclea A, et al. Brain Behav. 2017 Jul 11;7(8):e00761. doi: 10.1002/brb3.761. eCollection 2017 Aug. Brain Behav. 2017. PMID: 28828221 Free PMC article.

3

Prediction of conversion to multiple sclerosis using the 2017 McDonald and 2016 MAGNIMS criteria in patients with clinically isolated syndrome: a retrospective single-centre study.

Miclea A, Salmen A, Wiest R, Zoehner G, Wagner F, Hoepner A, Schrewe L, Evangelopoulos ME, Kamber N, Chan A, Hoepner R. Miclea A, et al. Ther Adv Neurol Disord. 2019 Mar 29;12:1756286419835652. doi: 10.1177/1756286419835652. eCollection 2019. Ther Adv Neurol Disord. 2019. PMID: 30956685 Free PMC article. No abstract available.

4

Immunotherapies and COVID-19 mortality: a multidisciplinary open data analysis based on FDA's Adverse Event Reporting System.

Pistor M, Hoepner AGF, Lin Y, Jung S, Bassetti CL, Chan A, Salmen A, Hoepner R. Pistor M, et al. Among authors: hoepner agf. Ann Rheum Dis. 2021 Dec;80(12):1633-1635. doi: 10.1136/annrheumdis-2021-220679. Epub 2021 Jul 20. Ann Rheum Dis. 2021. PMID: 34285050 Free PMC article. No abstract available.

5

The impact of immunotherapies on COVID-19 case fatality rates during the US vaccination campaign: a multidisciplinary open data analysis using FDA Adverse Event Reporting System and Our World in Data.

Salmen A, Marti S, Hoepner AGF, Chan A, Hoepner R. Salmen A, et al. Among authors: hoepner agf. Front Pharmacol. 2023 Jun 15;14:1186404. doi: 10.3389/fphar.2023.1186404. eCollection 2023. Front Pharmacol. 2023. PMID: 37397473 Free PMC article.

6

Socioeconomic and Regional Disparities in Industry-Sponsored Clinical Trials in Multiple Sclerosis.

Marti S, Hoepner AGF, Hammer H, Salmen A, Chan A, Hoepner R. Marti S, et al. Among authors: hoepner agf. JAMA Netw Open. 2023 Nov 1;6(11):e2345619. doi: 10.1001/jamanetworkopen.2023.45619. JAMA Netw Open. 2023. PMID: 38019519 Free PMC article.

7

In the Name of COVID-19: Is the ECB Fuelling the Climate Crisis?

Cojoianu TF, Collins E, Hoepner AGF, Magill D, O'Neill T, Schneider FI. Cojoianu TF, et al. Among authors: hoepner agf. Environ Resour Econ (Dordr). 2020 Jul 9:1-7. doi: 10.1007/s10640-020-00450-z. Online ahead of print. Environ Resour Econ (Dordr). 2020. PMID: 32836830 Free PMC article.

8

Corporate emissions targets and the neglect of future innovators.

Robiou du Pont Y, Rogelj J, Hsu A, van Vuuren D, Hoepner AGF. Robiou du Pont Y, et al. Among authors: hoepner agf. Science. 2024 Apr 26;384(6694):388-390. doi: 10.1126/science.adl5081. Epub 2024 Apr 25. Science. 2024. PMID: 38662813

9

Virtues of impact financing: Do financial institutions benefit from considering the environmental impact on financing decisions?

Gao Y, Hoepner AGF. Gao Y, et al. Among authors: hoepner agf. J Environ Manage. 2024 Mar;354:120259. doi: 10.1016/j.jenvman.2024.120259. Epub 2024 Feb 13. J Environ Manage. 2024. PMID: 38350274

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page